Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel
AIIA partners with Startup India with the aim to identify and support innovations and start-ups working in the Ayush sector
The insights collected by the app will support the pharmaceutical industry’s efforts to further improve patients’ lives by providing actionable data on patients’ individual experiences
Merck is studying the Complete Response Letter and it is not related to the safety of gefapixant
The tele-heath market in India is expected to touch US $ 5.4 billion by 2025 and the adoption of tele-health has accelerated with the onset of Covid-19 in 2020. We caught up with Jeya Kumar, Founder and MD, RaphaCure, a prominent player in this segment and he outlined the opportunities that lie ahead for this segment
Market data indicates that more than twenty percent of the new chemical entities being developed use roller compaction technology in their development and commercialization
The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.
Subscribe To Our Newsletter & Stay Updated
